Recently, MAO-B inhibitors have grabbed the attention of several types of cancer treatments due to an evidenced correlation between MAO-B overexpression and several cancers, such as glioblastoma and colorectal cancer [2]. The gene discussed is MAOB; the disease is glioblastoma.